Advancing AAV technology: From capsid design to scalable manufacturing
Mol Ther Methods Clin Dev
.
2025 May 7;33(2):101477.
doi: 10.1016/j.omtm.2025.101477.
eCollection 2025 Jun 12.
Authors
Daniel Stone
1
,
Mario Mietzsch
2
,
Giuseppe Ronzitti
3
4
Affiliations
1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
2
Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, USA.
3
Genethon, 91000 Evry, France.
4
Université Paris-Saclay, University Evry, Inserm, Genethon, Integrare Research Unit UMR_S951, 91000 Evry, France.
PMID:
40469752
PMCID:
PMC12134569
DOI:
10.1016/j.omtm.2025.101477
No abstract available
Publication types
Editorial